# Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease

> **NCT02476526** · PHASE4 · COMPLETED · sponsor: **VA Greater Los Angeles Healthcare System** · enrollment: 50 (actual)

## Conditions studied

- Chronic Kidney Disease
- Pulmonary Embolism
- Renal Artery Stenosis
- Pulmonary Cancer

## Interventions

- **DRUG:** Low Volume iso-osmolar non-ionic radio contrast medium
- **DRUG:** Acetylcysteine Inhalation
- **DRUG:** Sodium Bicarbonate Solution
- **PROCEDURE:** 64-MDCT Scanning

## Key facts

- **NCT ID:** NCT02476526
- **Lead sponsor:** VA Greater Los Angeles Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2017-11-20
- **Final completion:** 2017-11-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-11-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02476526

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02476526, "Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02476526. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*